A phase III trial to compare standard versus accelerated fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG (1129): Report of compliance and toxicity

被引：6

作者：

Ang, K. ^{[1
]}

Pajak, T. ^{[2
]}

Rosenthall, D. I. ^{[1
]}

Nguyen, F. ^{[3
]}

Lu, C. ^{[1
]}

Kim, H. ^{[4
]}

Axelrod, R. ^{[5
]}

List, M. ^{[6
]}

Silverman, C. ^{[7
]}

Weber, R. S. ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

[2] Amer Coll Radiol, Philadelphia, PA USA

[3] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada

[4] Wayne State Univ, Sch Med, Detroit, MI USA

[5] Thomas Jefferson Univ, Philadelphia, PA USA

[6] Univ Chicago, Chicago, IL USA

[7] Univ Louisville, Louisville, KY USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2007.07.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S12 / S13

页数：2